JOHN BELMONT to Bone Marrow Cells
This is a "connection" page, showing publications JOHN BELMONT has written about Bone Marrow Cells.
Connection Strength
0.293
-
Enrichment and functional characterization of Sca-1+WGA+, Lin-WGA+, Lin-Sca-1+, and Lin-Sca-1+WGA+ bone marrow cells from mice with an Ly-6a haplotype. Blood. 1993 Nov 01; 82(9):2673-83.
Score: 0.098
-
Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells. Blood. 1992 Mar 15; 79(6):1393-9.
Score: 0.087
-
The receptor tyrosine kinase-related gene (ryk) demonstrates lineage and stage-specific expression in hematopoietic cells. J Immunol. 1995 Feb 01; 154(3):1157-66.
Score: 0.027
-
Leukemia inhibitory factor improves survival of retroviral vector-infected hematopoietic stem cells in vitro, allowing efficient long-term expression of vector-encoded human adenosine deaminase in vivo. J Exp Med. 1991 Oct 01; 174(4):837-45.
Score: 0.021
-
Murine leukemia inhibitory factor enhances retroviral-vector infection efficiency of hematopoietic progenitors. Blood. 1990 Sep 15; 76(6):1098-103.
Score: 0.020
-
Expression of human adenosine deaminase in murine hematopoietic cells. Mol Cell Biol. 1988 Dec; 8(12):5116-25.
Score: 0.017
-
Bcr-Abl-mediated suppression of normal hematopoiesis in leukemia. Oncogene. 2005 May 05; 24(20):3246-56.
Score: 0.014
-
Use of cell-free retroviral vector preparations for transduction of cells from the marrow of chronic phase and blast crisis chronic myelogenous leukemia patients and from normal individuals. Hum Gene Ther. 1992 Apr; 3(2):137-45.
Score: 0.005
-
Gene replacement therapy for inborn errors of purine metabolism. Cold Spring Harb Symp Quant Biol. 1986; 51 Pt 2:1065-71.
Score: 0.004